期刊文献+

功能性消化不良的病因机制及西医治疗 被引量:7

下载PDF
导出
摘要 功能性消化不良(functional dyspepsia,FD)是一个临床上很常见的症候群.一般认为,持续性或反复发作性的上腹部不适,并具有下列一个或几个症状:餐后饱胀、腹部胀气、嗳气、早饱(进正常食量未完即感饱胀而弃食)、厌食、恶心、呕吐、烧心、胸骨后痛、反胃,且慢性的期限在3个月以上(也有将病程定为1个月以上),经胃镜、上胃肠钡餐造影、腹部B超和各种化验检查无异常者称为功能性消化不良.功能性消化不良是有临床表现,而未发现器质性病变,却使患者深感痛苦的病症.因为其发病极其广泛,几与一般感冒同样多见,但对人民健康和社会劳动力的影响甚为严重,而且构成相当高的医疗费用,因此已逐渐成为现代社会中一个重要的医疗保健问题.下面就功能性消化不良的病因机制及西医治疗作一介绍.
作者 韩金娥
出处 《医学理论与实践》 2003年第4期408-409,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献5

二级参考文献10

  • 1[1]Stables R, Campbell CJ, Clayton NM, et al. Gastric anti-secretory, mucosal protective, anti-Helicobacter properties of ranitidine bismuth citrae. Aliment Pharmacol Ther,1993;7:237~246.
  • 2[2]Lacey LF, Frazer NM, Keene ON, et al. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X) , a novel anti-ulcerant and tripotassium dicitrato bismuthate(TDB). Eur J Pharmacol, 1994;47:177~180.
  • 3[3]Bardhan KD, Dekkers CP , Lam SK, et al. GR122311X(ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther, 1995;9:497~506.
  • 4[4]Laine L, Estrada R, Trujillo M, et al. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Am J Gastroenterol, 1997;92:2213~2215.
  • 5[5]Van der Wouden EJ, Thijs JC, van Zwet AA, et al. One week triple therapy with ranitidine bismuth citrate, clarithromycine and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycine for Helicobacter pylori infection: a randomized, clinical trial. Am J Gastroenterol, 1998, 93:1228~1231.
  • 6[6]Spadaccini A, De Fanis C, Sciampa G, et al. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Aliment Pharmacol Ther, 1998;12:997~1001.
  • 7[7]Gasbarrini A, Ojetti V, Armuzzi A, et al. Efficacy of a multistep strategy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000;14:79~83.
  • 8[8]Spinzi GC, Boni F, Bortoli A, et al. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. Aliment Pharmacol Ther, 2000;14: 325~330.
  • 9[9]Kung NN, Sung JJ, Yuen NW, et al. One week ranitidine bismuth citrate versus colloidal subcitrate based anti-Helicobacter tripletherapy: a prospective randomized controlled trial. Am J Gastroenterol, 1999;94:721~724.
  • 10胡伏莲.重视幽门螺杆菌耐药株的研究[J].中华医学杂志,2000,80(11):805-806. 被引量:12

共引文献89

同被引文献58

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部